HEMISPHERE ENERGY CORP (HME.CA) Fundamental Analysis & Valuation

TSX-V:HME • CA4236301020

Current stock price

2.84 CAD
-0.02 (-0.7%)
Last:

This HME.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. HME.CA Profitability Analysis

1.1 Basic Checks

  • In the past year HME was profitable.
  • HME had a positive operating cash flow in the past year.
  • HME had positive earnings in each of the past 5 years.
  • In the past 5 years HME always reported a positive cash flow from operatings.
HME.CA Yearly Net Income VS EBIT VS OCF VS FCFHME.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M

1.2 Ratios

  • The Return On Assets of HME (23.12%) is better than 98.06% of its industry peers.
  • HME has a Return On Equity of 34.75%. This is amongst the best in the industry. HME outperforms 98.54% of its industry peers.
  • HME's Return On Invested Capital of 29.46% is amongst the best of the industry. HME outperforms 99.03% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for HME is significantly above the industry average of 6.84%.
Industry RankSector Rank
ROA 23.12%
ROE 34.75%
ROIC 29.46%
ROA(3y)26.51%
ROA(5y)23.13%
ROE(3y)39.59%
ROE(5y)36.39%
ROIC(3y)32.46%
ROIC(5y)33.96%
HME.CA Yearly ROA, ROE, ROICHME.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

  • HME has a better Profit Margin (29.84%) than 94.66% of its industry peers.
  • In the last couple of years the Profit Margin of HME has grown nicely.
  • HME's Operating Margin of 42.20% is amongst the best of the industry. HME outperforms 92.23% of its industry peers.
  • HME's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 60.69%, HME is in the better half of the industry, outperforming 78.16% of the companies in the same industry.
  • HME's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 42.2%
PM (TTM) 29.84%
GM 60.69%
OM growth 3Y-2.15%
OM growth 5Y14.92%
PM growth 3Y10.62%
PM growth 5YN/A
GM growth 3Y0.24%
GM growth 5Y1.06%
HME.CA Yearly Profit, Operating, Gross MarginsHME.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. HME.CA Health Analysis

2.1 Basic Checks

  • HME has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, HME has less shares outstanding
  • The number of shares outstanding for HME has been increased compared to 5 years ago.
  • The debt/assets ratio for HME has been reduced compared to a year ago.
HME.CA Yearly Shares OutstandingHME.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
HME.CA Yearly Total Debt VS Total AssetsHME.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • An Altman-Z score of 6.14 indicates that HME is not in any danger for bankruptcy at the moment.
  • HME has a Altman-Z score of 6.14. This is amongst the best in the industry. HME outperforms 85.92% of its industry peers.
  • HME has a debt to FCF ratio of 0.09. This is a very positive value and a sign of high solvency as it would only need 0.09 years to pay back of all of its debts.
  • HME has a Debt to FCF ratio of 0.09. This is amongst the best in the industry. HME outperforms 96.60% of its industry peers.
  • A Debt/Equity ratio of 0.03 indicates that HME is not too dependend on debt financing.
  • HME's Debt to Equity ratio of 0.03 is fine compared to the rest of the industry. HME outperforms 76.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.09
Altman-Z 6.14
ROIC/WACC3.63
WACC8.11%
HME.CA Yearly LT Debt VS Equity VS FCFHME.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 1.37 indicates that HME should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.37, HME is in the better half of the industry, outperforming 68.93% of the companies in the same industry.
  • A Quick Ratio of 1.37 indicates that HME should not have too much problems paying its short term obligations.
  • HME has a Quick ratio of 1.37. This is in the better half of the industry: HME outperforms 69.90% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.37
HME.CA Yearly Current Assets VS Current LiabilitesHME.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. HME.CA Growth Analysis

3.1 Past

  • HME shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.15%.
  • The Earnings Per Share has been growing by 10.83% on average over the past years. This is quite good.
  • Looking at the last year, HME shows a decrease in Revenue. The Revenue has decreased by -6.07% in the last year.
  • HME shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 38.14% yearly.
EPS 1Y (TTM)-15.15%
EPS 3Y10.83%
EPS 5YN/A
EPS Q2Q%-28.57%
Revenue 1Y (TTM)-6.07%
Revenue growth 3Y-0.99%
Revenue growth 5Y38.14%
Sales Q2Q%-18.71%

3.2 Future

  • HME is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -16.11% yearly.
  • HME is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -7.33% yearly.
EPS Next Y-8.04%
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
EPS Next 5YN/A
Revenue Next Year-9.27%
Revenue Next 2Y-4.18%
Revenue Next 3Y-7.33%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HME.CA Yearly Revenue VS EstimatesHME.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M 100M
HME.CA Yearly EPS VS EstimatesHME.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2022 2023 2024 2025 2026 2027 2028 0 0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

7

4. HME.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 10.14, the valuation of HME can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Earnings ratio of HME indicates a somewhat cheap valuation: HME is cheaper than 75.73% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of HME to the average of the S&P500 Index (27.42), we can say HME is valued rather cheaply.
  • The Price/Forward Earnings ratio is 11.03, which indicates a very decent valuation of HME.
  • 74.76% of the companies in the same industry are more expensive than HME, based on the Price/Forward Earnings ratio.
  • HME is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.24, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.14
Fwd PE 11.03
HME.CA Price Earnings VS Forward Price EarningsHME.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HME indicates a rather cheap valuation: HME is cheaper than 90.78% of the companies listed in the same industry.
  • HME's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HME is cheaper than 90.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.39
EV/EBITDA 4.91
HME.CA Per share dataHME.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

  • HME has an outstanding profitability rating, which may justify a higher PE ratio.
  • HME's earnings are expected to decrease with -16.11% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. HME.CA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.50%, HME has a reasonable but not impressive dividend return.
  • HME's Dividend Yield is a higher than the industry average which is at 3.82.
  • HME's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 3.5%

5.2 History

  • HME has been paying a dividend for over 5 years, so it has already some track record.
  • HME has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
HME.CA Yearly Dividends per shareHME.CA Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • 54.76% of the earnings are spent on dividend by HME. This is a bit on the high side, but may be sustainable.
DP54.76%
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
HME.CA Yearly Income VS Free CF VS DividendHME.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M
HME.CA Dividend Payout.HME.CA Dividend Payout, showing the Payout Ratio.HME.CA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

HME.CA Fundamentals: All Metrics, Ratios and Statistics

HEMISPHERE ENERGY CORP

TSX-V:HME (4/24/2026, 7:00:00 PM)

2.84

-0.02 (-0.7%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)04-15
Earnings (Next)05-20
Inst Owners0.94%
Inst Owner ChangeN/A
Ins Owners10.46%
Ins Owner ChangeN/A
Market Cap267.81M
Revenue(TTM)93.86M
Net Income(TTM)28.01M
Analysts84.44
Price Target2.96 (4.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.5%
Yearly Dividend0.16
Dividend Growth(5Y)N/A
DP54.76%
Div Incr Years0
Div Non Decr Years3
Ex-Date05-14
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-11%
Min EPS beat(2)-19.09%
Max EPS beat(2)-2.91%
EPS beat(4)1
Avg EPS beat(4)-5.53%
Min EPS beat(4)-19.09%
Max EPS beat(4)2.8%
EPS beat(8)3
Avg EPS beat(8)-2.2%
EPS beat(12)4
Avg EPS beat(12)-3.78%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.09%
Min Revenue beat(2)-3.98%
Max Revenue beat(2)-0.21%
Revenue beat(4)2
Avg Revenue beat(4)1.55%
Min Revenue beat(4)-3.98%
Max Revenue beat(4)5.99%
Revenue beat(8)5
Avg Revenue beat(8)1.46%
Revenue beat(12)7
Avg Revenue beat(12)0.74%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.73%
PT rev (3m)19.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-9.09%
EPS NY rev (3m)-3.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.03%
Revenue NY rev (1m)-3.26%
Revenue NY rev (3m)-7.92%
Valuation
Industry RankSector Rank
PE 10.14
Fwd PE 11.03
P/S 2.85
P/FCF 8.39
P/OCF 5.56
P/B 3.32
P/tB 3.32
EV/EBITDA 4.91
EPS(TTM)0.28
EY9.86%
EPS(NY)0.26
Fwd EY9.07%
FCF(TTM)0.34
FCFY11.91%
OCF(TTM)0.51
OCFY17.98%
SpS1
BVpS0.85
TBVpS0.85
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.32039 (-18.3%)
Profitability
Industry RankSector Rank
ROA 23.12%
ROE 34.75%
ROCE 39.28%
ROIC 29.46%
ROICexc 36.52%
ROICexgc 36.52%
OM 42.2%
PM (TTM) 29.84%
GM 60.69%
FCFM 33.99%
ROA(3y)26.51%
ROA(5y)23.13%
ROE(3y)39.59%
ROE(5y)36.39%
ROIC(3y)32.46%
ROIC(5y)33.96%
ROICexc(3y)37.5%
ROICexc(5y)37.01%
ROICexgc(3y)37.5%
ROICexgc(5y)37.01%
ROCE(3y)43.29%
ROCE(5y)45.29%
ROICexgc growth 3Y-7.82%
ROICexgc growth 5Y43.82%
ROICexc growth 3Y-7.82%
ROICexc growth 5Y43.82%
OM growth 3Y-2.15%
OM growth 5Y14.92%
PM growth 3Y10.62%
PM growth 5YN/A
GM growth 3Y0.24%
GM growth 5Y1.06%
F-Score6
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.09
Debt/EBITDA 0.04
Cap/Depr 140.25%
Cap/Sales 17.31%
Interest Coverage 250
Cash Conversion 94.07%
Profit Quality 113.94%
Current Ratio 1.37
Quick Ratio 1.37
Altman-Z 6.14
F-Score6
WACC8.11%
ROIC/WACC3.63
Cap/Depr(3y)180.21%
Cap/Depr(5y)207.89%
Cap/Sales(3y)19.72%
Cap/Sales(5y)21.17%
Profit Quality(3y)100.55%
Profit Quality(5y)107.06%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.15%
EPS 3Y10.83%
EPS 5YN/A
EPS Q2Q%-28.57%
EPS Next Y-8.04%
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.07%
Revenue growth 3Y-0.99%
Revenue growth 5Y38.14%
Sales Q2Q%-18.71%
Revenue Next Year-9.27%
Revenue Next 2Y-4.18%
Revenue Next 3Y-7.33%
Revenue Next 5YN/A
EBIT growth 1Y-11.49%
EBIT growth 3Y-3.12%
EBIT growth 5Y58.75%
EBIT Next Year28.61%
EBIT Next 3Y-3.62%
EBIT Next 5YN/A
FCF growth 1Y29.21%
FCF growth 3Y5.96%
FCF growth 5Y32.87%
OCF growth 1Y3.47%
OCF growth 3Y2.22%
OCF growth 5Y38.68%

HEMISPHERE ENERGY CORP / HME.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HEMISPHERE ENERGY CORP (HME.CA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to HME.CA.


What is the valuation status for HME stock?

ChartMill assigns a valuation rating of 7 / 10 to HEMISPHERE ENERGY CORP (HME.CA). This can be considered as Undervalued.


What is the profitability of HME stock?

HEMISPHERE ENERGY CORP (HME.CA) has a profitability rating of 9 / 10.


Can you provide the financial health for HME stock?

The financial health rating of HEMISPHERE ENERGY CORP (HME.CA) is 7 / 10.


What is the earnings growth outlook for HEMISPHERE ENERGY CORP?

The Earnings per Share (EPS) of HEMISPHERE ENERGY CORP (HME.CA) is expected to decline by -8.04% in the next year.